Decreased susceptibility to vancomycin in meticillin-resistant Staphylococcus aureus: a 5 year study in an Indian tertiary hospital

References

1. Biedenbach D. J., Moet G. J., Jones R. N. 2004; Occurrence and antimicrobial resistance pattern comparisons among bloodstream infection isolates from the SENTRY Antimicrobial Surveillance Program (1997–2002. Diagn Microbiol Infect Dis 50:59–69 [CrossRef]
   [Google Scholar]
2. Chapman A. L., Greig J. M., Innes J. A. 2005; MRSA in the community. N Engl J Med 353:530–532 [CrossRef]
   [Google Scholar]
3. CLSI 2006a Performance Standards for Antimicrobial Susceptibility Testing , 16th informational supplement, M100–S16 Wayne, PA: Clinical and Laboratory Standards Institute;
   [Google Scholar]
4. CLSI 2006b Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically , 7th edn. approved standard M7–A7 Wayne, PA: Clinical and Laboratory Standards Institute;
   [Google Scholar]
5. Dhawan B., Gadepalli R., Kapil A. 2009; In vitro activity of daptomycin against Staphylococcus aureus and vancomycin-resistant Enterococcus faecium isolates associated with skin and soft tissue infections: first results from India. Diagn Microbiol Infect Dis 65:196–198 [CrossRef]
   [Google Scholar]
6. Fridkin S. K., Hageman J., McDougal L. K., Mohammed J., Jarvis W. R., Perl T. M., Tenover F. C for theVancomycin-Intermediate Staphylococcus aureus Epidemiology Study Group; (2003; Epidemiological and microbiological characterization of infections caused by Staphylococcus aureus with reduced susceptibility to vancomycin, United States, 1997–2001. Clin Infect Dis 36:429–439 [CrossRef]
   [Google Scholar]
7. Gadepalli R., Dhawan B., Kapil A., Sreenivas V., Jais M., Gaind R., Chaudhry R., Samantaray J. C., Udo E. E. 2009; Clinical and molecular characteristics of nosocomial meticillin-resistant Staphylococcus aureus skin and soft tissue isolates from three Indian hospitals. J Hosp Infect 73:253–263 [CrossRef]
   [Google Scholar]
8. Hiramatsu K., Aritaka N., Hanaki H., Kawasaki S., Hosoda Y., Hori S., Fukuchi Y., Kobayashi I. 1997; Dissemination in Japanese hospitals of strains of Staphylococcus aureus heterogeneously resistant to vancomycin. Lancet 350:1670–1673 [CrossRef]
   [Google Scholar]
9. Mathur P., Kapil A., Chandra R., Sharma P., Das B. 2003; Antimicrobial resistance in Enterococcus faecalis at a tertiary care centre of northern India. Indian J Med Res 118:25–28
   [Google Scholar]
10. NNISS 2004; National Nosocomial Infections Surveillance (NNIS) System report, data summary from January 1992 through June 2004, issued October 2004. Am J Infect Control 32:470–485 [CrossRef]
    [Google Scholar]
11. Ramos-Trujillo E., Pérez-Roth E., Méndez-Alvarez S., Claverie-Martín F. 2003; Multiplex PCR for simultaneous detection of enterococcal genes van A and van B and staphylococcal genes mec A, ileS -2 and fem B. Int Microbiol 6:113–115 [CrossRef]
    [Google Scholar]
12. Robert J., Bismuth R., Jarlier V. 2006; Decreased susceptibility to glycopeptides in methicillin-resistant Staphylococcus aureus : a 20 year study in a large French teaching hospital, 1983–2002. J Antimicrob Chemother 57:506–510 [CrossRef]
    [Google Scholar]
13. Sakoulas G., Moise-Broder P. A., Schentag J., Forrest A., Moellering R. C. Jr, Eliopoulos G. M. 2004; Relationship of MIC and bactericidal activity to efficacy of vancomycin for treatment of methicillin-resistant Staphylococcus aureus bacteremia. J Clin Microbiol 42:2398–2402 [CrossRef]
    [Google Scholar]
14. Tenover F. C. 2008; Vancomycin-resistant Staphylococcus aureus : a perfect but geographically limited storm?. Clin Infect Dis 46:675–677 [CrossRef]
    [Google Scholar]